Every roundup of weight loss affiliate programs quotes a single confident number per brand. Almost none of those numbers can be traced to the company that supposedly pays it.
Here is the problem in one example. For Ro, one affiliate network publishes a payout of “$24 to $40 depending on the item category” and another publishes $5. For Willow, the company’s own page says $30 and a network says $160. For Hims, a network listing dated 8 September 2026 says $4 per lead while a directory says $15 to $40. These are not small discrepancies, and there is no single correct figure to report, because different networks carry different offers for the same advertiser.
So this page does something different. Every figure below is labelled with where it came from and the date on that page. Checked 10 September 2026.
What the companies themselves publish
Only three brands in this category publish affiliate terms on their own website. That is the finding, not a gap in the research.
| Brand | Commission, as published by the brand | Cookie | Platform | Payout |
|---|---|---|---|---|
| WeightWatchers | “a base commission of $10 for every qualifying subscription” | Not published | Impact | Monthly by check, $25 minimum |
| Willow | “$30 CPA on purchases” | 30 days | Impact | Not published |
| GobyMeds | “flat-rate for each first-time customer”, amount not published | Not published | Not published | Net 30, no minimum, direct deposit or PayPal |
WeightWatchers is the only one of the three that publishes a payout floor and a schedule. Its page also states the program “is only accepting U.S.-based affiliates at this time.”
Note that WeightWatchers publishes no exclusion for its clinical or GLP-1 subscriptions, and no separate rate for them. If that distinction matters to your traffic, ask before assuming.
What the networks publish
These are network-published figures. The network is the party stating the rate, not the brand. Dates are the last-updated dates shown on each page.
| Brand | Payout | Cookie | Network | Page dated |
|---|---|---|---|---|
| Remote Pharmacy Weight Loss | “The payout is $350 per sale” | Not published | FlexOffers | 24 Feb 2026 |
| Fella Health | “$200 per sale (excluding sales from existing customers)” | 30 days | FlexOffers | 14 Aug 2026 |
| TrimRx | “Receive $100 per valid Credit Card Submit” | Not published | FlexOffers | 25 Mar 2026 |
| PlushCare | “Default Commission Rate: $60 CPA” | Not published | Katalys | 11 Oct 2024 |
| Alan Meds | “$16 to $60 depending on the item SKU” | 30 days | FlexOffers | 26 May 2025 |
| Sesame Care | “$0.80 to $80 depending on the item SKU and customer status” | 30 days | FlexOffers | 23 Feb 2025 |
| Ro | “$24 to $40 depending on the item category” | 30 days | FlexOffers | 4 Sep 2026 |
| Hims | “$4 commission per online lead” | 30 days | FlexOffers | 8 Sep 2026 |
| ShedRX | Not published | 30 days | Awin | Not dated |
Read the dates. A PlushCare figure last touched in October 2024 is nearly two years old. Katalys’ own pages carry the caveat that rates “may have changed since publication.” The FlexOffers Hims and Ro listings are recent and correspondingly more reliable.
One page-level caveat. FlexOffers currently serves its Hims program content at a URL slug belonging to an unrelated program. The content is correct, the URL is not. That is a defect on their side and it is worth knowing if you cite it.
FancyMeds contradicts itself
The FlexOffers listing for FancyMeds states “Earn 20-40% on referrals and a $100 flat fee for affiliate sign-ups” and separately lists “4% of sales” on the same page. Do not publish a single figure for this brand without asking.
Brands with no published program
Several well-known names in this category publish nothing at all: Found, Calibrate, Eden, Zealthy, Form Health and MyFitnessPal. Their sites carry only business-to-business partnership pages for employers and health plans.
Two are worth a specific note.
Calibrate has repositioned away from consumer. Its own announcement describes a completed transition to enterprise-focused obesity management. Any directory listing showing a consumer Calibrate affiliate program should be treated as stale.
LifeMD appears to run a private program. There is no published affiliate page, but LifeMD URLs carrying affiliate tracking parameters are indexed publicly. That pattern indicates an unpublished program open by invitation. The rate is not published anywhere.
Henry Meds has a live signup on Ascend by Partnerize but publishes no rate, cookie or payout terms on any primary or network page.
The part most roundups leave out
The binding constraints on this content do not come from the affiliate programs. Not one program in this research publishes a rule about how affiliates may describe prescription or compounded medication. The constraints come from the FDA and the FTC, and they apply to you regardless of what your program agreement says.
FDA guidance for promoting compounded drugs
The FDA published guidance specifically addressed to telehealth companies promoting compounded drugs. It names promotional framings that are not permitted, including:
- “describing a compounded drug as a generic version of an FDA-approved drug”
- “claiming a compounded drug has been FDA-approved or has otherwise been evaluated”
- “describing a compounded drug as clinically proven to produce the same result”
In March 2026 the FDA announced warning letters to 30 telehealth companies over marketing of compounded GLP-1 products, citing among other things “making claims implying sameness with FDA-approved products.”
An earlier warning letter to one telehealth company quoted the specific advertising copy the agency objected to, including a claim that a product had “the same active ingredient as” a named FDA-approved drug. That is a useful example of exactly what not to write.
FTC requirements that fall on you personally
- On disclosure: “You should disclose your relationship to the retailer clearly and conspicuously on your site.” The FTC has also stated that the phrase “affiliate link” on its own does not adequately communicate that you are paid.
- On substantiation: “you shouldn’t make claims about a product that would require proof the advertiser doesn’t have.”
- On testimonials: the FTC’s health products guidance states that attempts to disclaim dramatic results with statements like “Results not typical” do not cure the deception.
- On liability: “Anyone participating in deceptive marketing is potentially liable under FTC law.”
One claim you will see that is not supported
Several guides state that Google bans affiliate advertising of compounded GLP-1 medication. The policy text does not say that. What Google’s published policy says is that it “restricts the promotion of services related to the online prescribing, dispensing, and sale of prescription drugs” and that advertisers “must be certified by Google in order to serve ads for prescription drug services,” which may require third-party accreditation. That is a certification gate, not a compounding ban. We could not verify Meta’s current policy text from a primary source, so no Meta policy is quoted here.
This section summarises published regulator guidance and is not legal advice. Requirements change and enforcement is fact-specific. Consult qualified counsel before running campaigns in this category.
How to compare offers that are not comparable
The payouts above range from $0.80 to $350, which tells you almost nothing on its own, because they are measuring different events. A “valid credit card submit” and a completed subscription are not the same conversion.
Four questions worth asking any program in this category:
- What event triggers payment, exactly? A lead, a card submit, a first fill, or a retained subscriber.
- Is there a clawback on cancellation or refund? In a category with high early churn this matters more than the headline rate.
- Does the rate differ for new versus existing customers? Several programs here pay nothing on existing customers and do not say so prominently.
- What is the attribution window, and is it published by the brand or only by a network? Nearly every 30 day figure in this category is network-published, not brand-confirmed.
Related
- Best health affiliate programs
- Mental health affiliate programs
- Women’s health affiliate programs
- Hims affiliate program
- Hers affiliate program
- Noom affiliate program
- BlueChew affiliate program
- Our affiliate program
Sources
Brand-published:
Network-published:
Regulatory:
- FDA, what to know when promoting compounded drugs
- FDA warns 30 telehealth companies over compounded GLP-1 marketing
- FDA concerns about unapproved GLP-1 drugs used for weight loss
- FTC Endorsement Guides, what people are asking
- FTC Health Products Compliance Guidance
- Google Ads healthcare and medicines policy
Last reviewed 10 September 2026. Payouts, cookie windows and program availability change without notice, and several figures above come from network listings that were last updated more than a year ago. Verify against the source before making a commercial decision. Listing a program is not an endorsement of that company or its products.
This article is for general information. It is not medical advice and it is not a recommendation for any particular treatment. Whether a treatment is appropriate for you is a decision for a licensed clinician who has reviewed your health history and current medications.
